Caroline Serino-Silva
Papers
1
Total Citations
7
H-Index
1
About
Caroline Serino-Silva is a rising star in toxinology, whose work bridges fundamental venom biochemistry and translational therapeutic discovery. Her research centers on snake venom toxins, particularly phospholipases A2 (PLA2), and the natural inhibitors found in the blood of venom-resistant snakes. Her most cited study, "BoaγPLI from Boa constrictor Blood is a Broad-Spectrum Inhibitor of Venom PLA2 Pathophysiological Actions" (2021, 7 citations), represents a landmark contribution: it identifies and characterizes a novel gamma-type phospholipase inhibitor from boa constrictor plasma, demonstrating its ability to neutralize the local and systemic toxic effects of multiple viperid venoms. This work not only deepens our understanding of co-evolutionary arms races between predators and prey but also opens a promising avenue for developing next-generation antivenoms that are more effective against the tissue-destroying actions of snakebites. Though early in her career, Serino-Silva’s focused, high-impact output signals her as a key investigator in the search for broad-spectrum, low-immunogenicity alternatives to conventional antivenom therapy.
Research Focus
Key Achievements
Top Papers
- 1